Oxaliplatin in Treating Patients With Liver Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of oxaliplatin in treating patients who have
unresectable, recurrent or metastatic liver cancer. Drugs used in chemotherapy use different
ways to stop tumor cells from dividing so they stop growing or die.